# Glucagon‐like peptide‐1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: <scp>a</scp> systematic review and meta‐analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/glucagon-like-peptide-1-receptor-agonists-compared-with-basal-insulins-for-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sonal Singh,Eugene E. Wright,Anita Y. M. Kwan,Juliette C. Thompson,Iqra Syed,Ellen Korol,Nathalie Waser,Maria Yu,Rattan Juneja |
| Citations | 98 |
| DOI | 10.1111/dom.12805 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12805 |
| OpenAlex ID | https://openalex.org/W2528138059 |
| PMID | 27717130 |
| Type | review |
| Year | 2016 |

## Paper authors

- [Juliette C. Thompson](https://scholariq.org/researchers/juliette-c-thompson/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.